Today The National Institute for Health and Clinical Excellence (NICE) in England published a new guidelines set to improve identification,diagnosis and treatment of obsessive-compulsive disorder in children and adults.
Den amerikanske virksomhed Medtronic vil snart søge godkendelse hos den amerikanske lægemiddelstyrelse Food and Drug Agency om godkendelse af deres produkt Activa til behandling af behandlingsresistent OCD. Activa benytter Deeb Brain Stimulation terapi og er reversibel modsat for eksempel neurokirurgi.
Medscape Oct. 27, 2004.
News Author: Laurie Barclay, MD
Combined cognitive-behavior therapy (CBT) with sertraline may be best for adolescents with obsessive-compulsive disorder (OCD), according to the results of a randomized trial published in the Oct. 27 issue of JAMA. ï¿½The empirical literature on treatment of obsessive-compulsive disorder (OCD) in children and adolescents supports the efficacy of short-term OCD-specific cognitive behavior therapy (CBT) or medical management with selective serotonin reuptake inhibitors ([S]SRIs),ï¿½ write John S. March, MD, MPH, from Duke University Medical Center in Durham, North Carolina, and colleagues from the Pediatric OCD Treatment Study (POTS) Team. ï¿½However, little is known about their relative and combined efficacy.ï¿½ Læs resten